BioSpace News Archive

Vave Health, a maker of innovative handheld ultrasound technology, today announced Dr. Renee Dversdal as its chief medical officer.

Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the prestigious peer-reviewed scientific journal, today has published the results of Grifols’ AMBAR study.

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Monday, August 10, 2020, to discuss its second quarter 2020 financial results and provide a business update.

Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that all AVISE test offerings (CTD, Lupus, SLE Prognostic, SLE Monitor, APS, MTX and HCQ) will be a contracted covered service with TRICARE East managed care support contractor Humana Military to optimize the care of these patients.

Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders, announced today that it will report its unaudited financial results for the second quarter 2020 before the U.S. market opens on Tuesday, August 11, 2020.

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that it will release financial results for the second quarter of 2020 after the close of trading on Monday, August 10, 2020.

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its second quarter 2020 financial results before the open of the U.S. financial markets on Wednesday, August 5, 2020.

Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it has named Gad Berdugo as the Company’s Chief Business Officer.

TCR2 Therapeutics Inc. (Nasdaq: TCRR) (“TCR2” or the “Company”), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock

Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced it plans to release financial results from the second quarter 2020 on Tuesday, August 4, 2020, prior to the market open.